These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33965544)

  • 1. Towards catch-up therapy: evaluation of nucleophilic active pharmaceutical ingredients for the treatment of percutaneous VX poisoning, in-vial and in-vitro studies.
    Nahum V; Nili U; Bloch-Shilderman E; Smolkin B; Ashkenazi N
    Int J Pharm; 2021 Jun; 603():120689. PubMed ID: 33965544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Catch-up" therapy: combining antidotal treatment with dermal application of AHA following percutaneous VX poisoning in the domestic swine.
    Bloch-Shilderman E; Nili U; Nahum V; Smolkin B; Ashkenazi N
    Arch Toxicol; 2023 Oct; 97(10):2771-2783. PubMed ID: 37610476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RSDL decontamination of human skin contaminated with the nerve agent VX.
    Thors L; Lindberg S; Johansson S; Koch B; Koch M; Hägglund L; Bucht A
    Toxicol Lett; 2017 Mar; 269():47-54. PubMed ID: 28179194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient agent degradation within skin is important for decontamination of percutaneously exposed VX.
    Thors L; Wigenstam E; Qvarnström J; Bucht A
    Cutan Ocul Toxicol; 2021 Jun; 40(2):95-102. PubMed ID: 33759679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
    Joosen MJ; van der Schans MJ; Kuijpers WC; van Helden HP; Noort D
    Chem Biol Interact; 2013 Mar; 203(1):149-53. PubMed ID: 23085122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immobilization of Russian VX skin depots by localized cooling: implications for decontamination and medical countermeasures.
    Mikler J; Tenn C; Worek F; Reiter G; Thiermann H; Garrett M; Bohnert S; Sawyer TW
    Toxicol Lett; 2011 Sep; 206(1):47-53. PubMed ID: 21704135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic use of localized cooling in the treatment of VX poisoning.
    Sawyer TW; Mikler J; Worek F; Reiter G; Thiermann H; Tenn C; Weatherby K; Bohnert S
    Toxicol Lett; 2011 Jul; 204(1):52-6. PubMed ID: 21530621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin.
    Thors L; Koch M; Wigenstam E; Koch B; Hägglund L; Bucht A
    Chem Biol Interact; 2017 Aug; 273():82-89. PubMed ID: 28601555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of selected skin decontaminant products and regimens against VX in domestic swine.
    Bjarnason S; Mikler J; Hill I; Tenn C; Garrett M; Caddy N; Sawyer TW
    Hum Exp Toxicol; 2008 Mar; 27(3):253-61. PubMed ID: 18650258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure.
    Joosen MJ; van den Berg RM; de Jong AL; van der Schans MJ; Noort D; Langenberg JP
    Chem Biol Interact; 2017 Apr; 267():48-56. PubMed ID: 26855350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy skin exposure to VX in vitro: effectiveness of delayed decontamination.
    Rolland P; Bolzinger MA; Cruz C; Josse D; Briançon S
    Toxicol In Vitro; 2013 Feb; 27(1):358-66. PubMed ID: 22926045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of the chemical warfare agent O-ethyl S-2-diisopropylaminoethyl methylphosphonothiolate (VX) on soil following accelerant-based fire and liquid decontamination.
    Gravett MR; Hopkins FB; Self AJ; Webb AJ; Timperley CM; Riches JR
    Anal Bioanal Chem; 2014 Aug; 406(21):5121-35. PubMed ID: 24972874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations.
    Vallet V; Cruz C; Licausi J; Bazire A; Lallement G; Boudry I
    Toxicology; 2008 Apr; 246(1):73-82. PubMed ID: 18294748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro human skin decontamination efficacy of MOF-808 in decontamination lotion following exposure to the nerve agent VX.
    Larsson A; Qvarnström J; Lindberg S; Wigenstam E; Öberg L; Afshin Sander R; Johansson S; Bucht A; Thors L
    Toxicol Lett; 2021 Mar; 339():32-38. PubMed ID: 33370593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive skin decontamination lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure.
    Schwartz MD; Hurst CG; Kirk MA; Reedy SJ; Braue EH
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1971-9. PubMed ID: 22352732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
    Hamilton MG; Hill I; Conley J; Sawyer TW; Caneva DC; Lundy PM
    Mil Med; 2004 Nov; 169(11):856-62. PubMed ID: 15605929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
    Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
    Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo decontamination of the nerve agent VX using the domestic swine model.
    Misik J; Pavlik M; Novotny L; Pavlikova R; Chilcott RP; Cabal J; Kuca K
    Clin Toxicol (Phila); 2012 Nov; 50(9):807-11. PubMed ID: 22963275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Basic Clin Pharmacol Toxicol; 2005 Jul; 97(1):35-8. PubMed ID: 15943757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.